ArticleCureus2025
A Trajectory of Thyroid Function: From Thyrotoxic Paralysis to Post-ablative Hypothyroidism.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute flaccid paralysis can obscure the underlying endocrine cause in thyrotoxic periodic paralysis (TPP), a rare but potentially life-threatening presentation of Graves' disease. We describe a 23-year-old Cantonese man who presented with sudden bilateral proximal lower limb weakness and severe hypokalaemia after a high-carbohydrate meal. Subsequent investigations revealed thyrotoxicosis consistent with Graves' disease. Management involved prompt potassium replacement, propranolol, and cautious initiation of carbimazole to avoid overtreatment. The patient later underwent radioactive iodine ablation, which successfully resolved thyrotoxicosis but led to post-ablative hypothyroidism requiring levothyroxine. This case underscores that TPP may represent the initial clinical expression of thyroid disease and highlights the critical importance of timely identification, meticulous management, and continued surveillance to mitigate iatrogenic risks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.